Related Experiment Video

Updated: Jul 14, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy

H Le Guillou-Guillemette1, S Vallet, C Gaudy-Graffin

  • 1Laboratory of Virology, Department of Infectious Agents, University Hospital of Angers, 4 rue Larrey, 49933 Angers Cedex 9, France.

World Journal of Gastroenterology
|June 7, 2007
PubMed

Insights

Hepatitis C Virus (HCV) genetic diversity influences treatment response. Understanding viral polymorphism, particularly in E2, NS3, NS5A, and NS5B genes, is key to improving interferon and new drug therapies.

Area of Science:

  • Virology
  • Immunology
  • Genetics

Background:

  • Hepatitis C Virus (HCV) exhibits significant genetic variability due to its RNA polymerase lacking proofreading and high replication rates.
  • This genetic polymorphism results in classifications like clades, genotypes, subtypes, isolates, and quasispecies.
  • HCV genetic diversity is known to impact patient responses to Interferon therapy.

Purpose of the Study:

  • To review the viral basis of HCV genetic diversity.
  • To describe HCV genetic regions implicated in antiviral therapy resistance.
  • To explain mechanisms of Interferon resistance and new antiviral drug action.

Main Methods:

  • Review of existing literature on HCV genetic variability and its impact on therapy.
  • Detailed examination of viral genetic regions associated with resistance.
  • Analysis of mechanisms underlying Interferon resistance and novel antiviral drug efficacy.

Main Results:

  • HCV genetic variability, driven by polymerase error-proneness and replication, leads to diverse strains.
  • Specific viral regions, including the E2 gene and non-structural genes (NS3, NS5A, NS5B), are implicated in resistance to antiviral treatments.
  • Understanding these genetic factors is crucial for predicting and optimizing therapy outcomes.

Conclusions:

  • HCV's genetic diversity is a major factor influencing treatment outcomes.
  • Targeting specific viral genes and understanding resistance mechanisms are essential for developing effective HCV therapies.
  • This review provides insights into viral genetic diversity and its implications for current and future antiviral strategies.

More Related Videos

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...